{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:12:30Z","timestamp":1771873950039,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aberrant activation of the Hedgehog (HH) signaling is a critical driver in tumorigenesis. The Smoothened (SMO) receptor is one of the major upstream transducers of the HH pathway and a target for the development of anticancer agents. The SMO inhibitor Vismodegib (GDC-0449\/Erivedge) has been approved for treatment of basal cell carcinoma. However, the emergence of resistance during Vismodegib treatment and the occurrence of numerous side effects limit its use. Our group has recently discovered and developed novel and potent SMO inhibitors based on acylguanidine or acylthiourea scaffolds. Here, we show that the two acylguanidine analogs, compound (<jats:bold>1<\/jats:bold>) and its novel fluoride derivative (<jats:bold>2<\/jats:bold>), strongly reduce growth and self-renewal of melanoma cells, inhibiting the level of the HH signaling target GLI1 in a dose-dependent manner. Both compounds induce apoptosis and DNA damage through the ATR\/CHK1 axis. Mechanistically, they prevent G2 to M cell cycle transition, and induce signs of mitotic aberrations ultimately leading to mitotic catastrophe. In a melanoma xenograft mouse model, systemic treatment with <jats:bold>1<\/jats:bold> produced a remarkable inhibition of tumor growth without body weight loss in mice. Our data highlight a novel route for cell death induction by SMO inhibitors and support their use in therapeutic approaches for melanoma and, possibly, other types of cancer with active HH signaling.<\/jats:p>","DOI":"10.1038\/s41419-017-0142-0","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T09:14:48Z","timestamp":1517562888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe"],"prefix":"10.1038","volume":"9","author":[{"given":"Silvia","family":"Pietrobono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinforosa","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dapporto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-8924","authenticated-orcid":false,"given":"David","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Chiariello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosima","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Valoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-2339","authenticated-orcid":false,"given":"Fabrizio","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Petricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1197-1622","authenticated-orcid":false,"given":"Barbara","family":"Stecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"142_CR1","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2002","unstructured":"Ingham, P. W. & McMahon, A. P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059\u20133087 (2002).","journal-title":"Genes Dev."},{"key":"142_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy, P. A., Karhadkar, S. S. & Berman, D. M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324\u2013331 (2004).","journal-title":"Nature"},{"key":"142_CR3","first-page":"181","volume":"1805","author":"S Teglund","year":"2010","unstructured":"Teglund, S. & Toftg\u00e5rd, R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim. Biophys. Acta. 1805, 181\u2013208 (2010).","journal-title":"Biochim. Biophys. Acta."},{"key":"142_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.devcel.2016.07.026","volume":"38","author":"E Pak","year":"2016","unstructured":"Pak, E. & Segal, R. A. Hedgehog signal transduction: key players, oncogenic drivers, and cancer therapy. Dev. Cell. 38, 333\u2013344 (2016).","journal-title":"Dev. Cell."},{"key":"142_CR5","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1158\/1078-0432.CCR-11-2509","volume":"18","author":"R McMillan","year":"2012","unstructured":"McMillan, R. & Matsui, W. Molecular pathways: the hedgehog signaling pathway in cancer. Clin. Cancer Res. 18, 4883\u20134888 (2012).","journal-title":"Clin. Cancer Res."},{"key":"142_CR6","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1101\/gad.1025302","volume":"16","author":"JK Chen","year":"2002","unstructured":"Chen, J. K., Taipale, J., Cooper, M. K. & Beachy, P. A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743\u20132748 (2002).","journal-title":"Genes Dev."},{"key":"142_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/35023008","volume":"406","author":"J Taipale","year":"2000","unstructured":"Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005\u20131009 (2000).","journal-title":"Nature"},{"key":"142_CR8","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3389","volume":"19","author":"D Amakye","year":"2013","unstructured":"Amakye, D., Jagani, Z. & Dorsch, M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 19, 1410\u20131422 (2013).","journal-title":"Nat. Med."},{"key":"142_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/OTT.S21957","volume":"5","author":"TL Lin","year":"2012","unstructured":"Lin, T. L. & Matsui, W. Hedgehog pathway as a drug target: Smoothened inhibitors in development. Onco. Targets Ther. 5, 47\u201358 (2012).","journal-title":"Onco. Targets Ther."},{"key":"142_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.1179386","volume":"326","author":"RL Yauch","year":"2009","unstructured":"Yauch, R. L. et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572\u2013574 (2009).","journal-title":"Science"},{"key":"142_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","volume":"27","author":"SX Atwood","year":"2015","unstructured":"Atwood, S. X. et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 27, 342\u2013353 (2015).","journal-title":"Cancer Cell."},{"key":"142_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","volume":"27","author":"HJ Sharpe","year":"2015","unstructured":"Sharpe, H. J. et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 27, 327\u2013341 (2015).","journal-title":"Cancer Cell."},{"key":"142_CR13","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2015.3","volume":"17","author":"S Pandolfi","year":"2015","unstructured":"Pandolfi, S. & Stecca, B. Cooperative integration between HEDGEHOG-GLI signaling and other oncogenic pathways: implications for cancer therapy. Expert. Rev. Mol. Med. 17, e5 (2015).","journal-title":"Expert. Rev. Mol. Med."},{"key":"142_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tips.2015.05.006","volume":"36","author":"P Infante","year":"2015","unstructured":"Infante, P., Alfonsi, R., Botta, B., Mori, M. & Di Marcotullio, L. Targeting GLI factors to inhibit the Hedgehog pathway. Trends Pharmacol. Sci. 36, 547\u2013558 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"142_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","volume":"71","author":"GJ Dijkgraaf","year":"2011","unstructured":"Dijkgraaf, G. J. et al. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res. 71, 435\u2013444 (2011).","journal-title":"Cancer Res."},{"key":"142_CR16","doi-asserted-by":"publisher","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","volume":"2","author":"S Buonamici","year":"2010","unstructured":"Buonamici, S. et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci. Transl. Med. 2, 51ra70 (2010).","journal-title":"Sci. Transl. Med."},{"key":"142_CR17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1021\/jm2013369","volume":"55","author":"A Solinas","year":"2012","unstructured":"Solinas, A. et al. Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. J. Med. Chem. 55, 1559\u20131571 (2012).","journal-title":"J. Med. Chem."},{"key":"142_CR18","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1096\/fj.14-267849","volume":"29","author":"L Hoch","year":"2015","unstructured":"Hoch, L. et al. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. FASEB. J. 29, 1817\u20131829 (2015).","journal-title":"FASEB. J."},{"key":"142_CR19","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1073\/pnas.182542899","volume":"99","author":"JK Chen","year":"2002","unstructured":"Chen, J. K., Taipale, J., Young, K. E., Maiti, T. & Beachy, P. A. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 99, 14071\u201314076 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR20","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1073\/pnas.0609699104","volume":"104","author":"M Lauth","year":"2007","unstructured":"Lauth, M., Bergstr\u00f6m, A., Shimokawa, T. & Toftg\u00e5rd, R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA 104, 8455\u20138460 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.124.13.2537","volume":"124","author":"J Lee","year":"1997","unstructured":"Lee, J., Platt, K. A. & Censullo, P. & Ruiz i Altaba, A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124, 2537\u20132552 (1997).","journal-title":"Development"},{"key":"142_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/13031","volume":"1","author":"P Kogerman","year":"1999","unstructured":"Kogerman, P. et al. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of GLI1. Nat. Cell. Biol. 1, 312\u2013319 (1999).","journal-title":"Nat. Cell. Biol."},{"key":"142_CR23","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1073\/pnas.0700776104","volume":"104","author":"B Stecca","year":"2007","unstructured":"Stecca, B. et al. Melanomas require Hedgehog-Gli signaling regulated by interactions between Gli1 and the RAS-MEK\/AKT pathways. Proc. Natl. Acad. Sci. USA 104, 5895\u20135900 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/ph6111429","volume":"6","author":"KE O\u2019Reilly","year":"2013","unstructured":"O\u2019Reilly, K. E. et al. Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. Pharmaceuticals (Basel) 6, 1429\u20131450 (2013).","journal-title":"Pharmaceuticals (Basel)"},{"key":"142_CR25","doi-asserted-by":"publisher","first-page":"e69064","DOI":"10.1371\/journal.pone.0069064","volume":"8","author":"A Jalili","year":"2013","unstructured":"Jalili, A. et al. NVP-lde225, a potent and selective smoothened antagonist reduces melanoma growth in vitro and in vivo. PLoS ONE 8, e69064 (2013).","journal-title":"PLoS ONE"},{"key":"142_CR26","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijms15033403","volume":"15","author":"LH Swift","year":"2014","unstructured":"Swift, L. H. & Golsteyn, R. M. Genotoxic anticancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells. Int J. Mol. Sci. 15, 3403\u20133431 (2014).","journal-title":"Int J. Mol. Sci."},{"key":"142_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1101\/gad.13.2.152","volume":"13","author":"RS Tibbetts","year":"1999","unstructured":"Tibbetts, R. S. et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152\u2013p157 (1999).","journal-title":"Genes Dev."},{"key":"142_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.gpb.2016.05.001","volume":"14","author":"H Wei","year":"2016","unstructured":"Wei, H. & Yu, X. Functions of PARylation in DNA damage repair pathways. Genom. Proteom. Bioinforma. 14, 131\u2013139 (2016).","journal-title":"Genom. Proteom. Bioinforma."},{"key":"142_CR29","doi-asserted-by":"publisher","first-page":"47759","DOI":"10.1074\/jbc.C100569200","volume":"276","author":"IM Ward","year":"2001","unstructured":"Ward, I. M. & Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276, 47759\u201347762 (2001).","journal-title":"J. Biol. Chem."},{"key":"142_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609\u2013619 (1993).","journal-title":"Cell"},{"key":"142_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell. Biol. 12, 385\u2013392 (2011).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"142_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1083\/jcb.153.1.121","volume":"153","author":"N den Elzen","year":"2001","unstructured":"den Elzen, N. & Pines, J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J. Cell. Biol. 153, 121\u2013136 (2001).","journal-title":"J. Cell. Biol."},{"key":"142_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1083\/jcb.153.1.137","volume":"153","author":"S Geley","year":"2001","unstructured":"Geley, S. et al. Anaphase-promoting complex\/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell. Biol. 153, 137\u2013148 (2001).","journal-title":"J. Cell. Biol."},{"key":"142_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","volume":"22","author":"C Crosio","year":"2002","unstructured":"Crosio, C. et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22, 874\u2013885 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"142_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0092-8674(87)90458-2","volume":"49","author":"P Russell","year":"1987","unstructured":"Russell, P. & Nurse, P. Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell 49, 559\u2013567 (1987).","journal-title":"Cell"},{"key":"142_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccr.2010.08.011","volume":"18","author":"SE Mir","year":"2010","unstructured":"Mir, S. E. et al. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell. 18, 244\u2013257 (2010).","journal-title":"Cancer Cell."},{"key":"142_CR37","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.4161\/cc.26062","volume":"12","author":"K Do","year":"2013","unstructured":"Do, K., Doroshow, J. H. & Kummar, S. Wee1 kinase as a target for cancer therapy. Cell Cycle 12, 3159\u20133164 (2013).","journal-title":"Cell Cycle"},{"key":"142_CR38","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers7030851","volume":"7","author":"CR Cochrane","year":"2015","unstructured":"Cochrane, C. R., Szczepny, A., Watkins, D. N. & Cain, J. E. Hedgehog signaling in the maintenance of cancer stem cells. Cancers (Basel) 7, 1554\u20131585 (2015).","journal-title":"Cancers (Basel)"},{"key":"142_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1158\/1078-0432.CCR-14-0507","volume":"21","author":"V Justilien","year":"2015","unstructured":"Justilien, V. & Fields, A. P. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clin. Cancer Res. 21, 505\u2013513 (2015).","journal-title":"Clin. Cancer Res."},{"key":"142_CR40","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/stem.1160","volume":"30","author":"R Santini","year":"2012","unstructured":"Santini, R. et al. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 30, 1808\u20131818 (2012).","journal-title":"Stem Cells"},{"key":"142_CR41","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jid.2016.06.610","volume":"136","author":"S Pietrobono","year":"2016","unstructured":"Pietrobono, S. et al. Down-regulation of SOX2 underlies the inhibitory effects of the triphenylmethane gentian violet on melanoma cell self-renewal and survival. J. Invest. Dermatol. 136, 2059\u20132069 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"142_CR42","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1073\/pnas.0712216105","volume":"105","author":"Y Abe","year":"2008","unstructured":"Abe, Y. et al. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc. Natl. Acad. Sci. USA 105, 4838\u20134843 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/emboj.2009.16","volume":"28","author":"B Stecca","year":"2009","unstructured":"Stecca, B. & Ruiz i Altaba, A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 28, 663\u2013676 (2009).","journal-title":"EMBO J."},{"key":"142_CR44","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/cdd.2013.120","volume":"20","author":"D Mazz\u00e0","year":"2013","unstructured":"Mazz\u00e0, D. et al. PCAF ubiquitin ligase activity inhibits Hedgehog\/Gli1 signaling in p53-dependent response to genotoxic stress. Cell. Death. Differ. 20, 1688\u20131697 (2013).","journal-title":"Cell. Death. Differ."},{"key":"142_CR45","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.2002906","volume":"5","author":"DJ Robbins","year":"2012","unstructured":"Robbins, D. J., Fei, D. L. & Riobo, N. A. The Hedgehog signal transduction network. Sci. Signal. 5, re6 (2012).","journal-title":"Sci. Signal."},{"key":"142_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.195","volume":"7","author":"P Infante","year":"2016","unstructured":"Infante, P. et al. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype. Cell Death Dis. 7, e2376 (2016).","journal-title":"Cell Death Dis."},{"key":"142_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01942-7","volume":"7","author":"V Kumar","year":"2017","unstructured":"Kumar, V. et al. Design, synthesis and biological evaluation of novel Hedgehog inhibitors for treating pancreatic cancer. Sci. Rep. 7, 1665 (2017).","journal-title":"Sci. Rep."},{"key":"142_CR48","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1101\/gad.914401","volume":"15","author":"RT Abraham","year":"2001","unstructured":"Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177\u20132196 (2001).","journal-title":"Genes Dev."},{"key":"142_CR49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0962-8924(02)02380-2","volume":"12","author":"AJ Osborn","year":"2002","unstructured":"Osborn, A. J., Elledge, S. J. & Zou, L. Checking on the fork: the DNA replication stress-response pathway. Trends Cell. Biol. 12, 509\u2013516 (2002).","journal-title":"Trends Cell. Biol."},{"key":"142_CR50","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1158\/0008-5472.CAN-10-4173","volume":"71","author":"T Mazumdar","year":"2011","unstructured":"Mazumdar, T., DeVecchio, J., Agyeman, A., Shi, T. & Houghton, J. A. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res. 71, 5904\u20135914 (2011).","journal-title":"Cancer Res."},{"key":"142_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L. et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell. Death. Differ. 19, 107\u2013120 (2012).","journal-title":"Cell. Death. Differ."},{"key":"142_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.11.002","volume":"24","author":"TV Denisenko","year":"2016","unstructured":"Denisenko, T. V., Sorokina, I. V., Gogvadze, V. & Zhivotovsky, B. Mitotic catastrophe and cancer drug resistance: a link that must to be broken. Drug. Resist. Updat. 24, 1\u201312 (2016).","journal-title":"Drug. Resist. Updat."},{"key":"142_CR53","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo, M. et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825\u20132837 (2004).","journal-title":"Oncogene"},{"key":"142_CR54","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1038\/onc.2014.71","volume":"33","author":"R Santini","year":"2014","unstructured":"Santini, R. et al. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene 33, 4697\u20134708 (2014).","journal-title":"Oncogene"},{"key":"142_CR55","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/cdd.2015.56","volume":"22","author":"S Pandolfi","year":"2015","unstructured":"Pandolfi, S., Montagnani, V., Lapucci, A. & Stecca, B. HEDGEHOG\/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth. Cell. Death. Differ. 22, 2006\u20132019 (2015).","journal-title":"Cell. Death. Differ."},{"key":"142_CR56","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1038\/onc.2012.502","volume":"32","author":"S Pandolfi","year":"2013","unstructured":"Pandolfi, S. et al. WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. Oncogene 32, 4737\u20134747 (2013).","journal-title":"Oncogene"},{"key":"142_CR57","doi-asserted-by":"crossref","first-page":"20981","DOI":"10.18632\/oncotarget.8044","volume":"7","author":"M Rossi","year":"2016","unstructured":"Rossi, M. et al. MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors. Oncotarget 7, 20981\u201320998 (2016).","journal-title":"Oncotarget"},{"key":"142_CR58","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1021\/acs.jmedchem.7b00527","volume":"60","author":"I Monaco","year":"2017","unstructured":"Monaco, I. et al. Aptamer functionalization of nanosystems for glioblastoma targeting through the blood-brain barrier. J. Med. Chem. 60, 4510\u20134516 (2017).","journal-title":"J. Med. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0142-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:39:39Z","timestamp":1671536379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0142-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0142-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"142"}}